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ARTICLE SUMMARY 
mcr-1 renders colistin ineffective, which is of relevance to the management of drug-
resistant Enterobacteriaceae infections. We highlight rapid increases in human 
gastrointestinal mcr-1 carriage prevalence (2011-2016, Guangzhou), using bacterial 
genomics to characterize the genetic diversity facilitating mcr-1 spread amongst 
humans/animals. 
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ABSTRACT 
Objectives 
mcr-1-mediated colistin resistance in Enterobacteriaceae is concerning, as colistin is 
used in treating multidrug-resistant Enterobacteriaceae infections. Rates of human mcr-1 
gastrointestinal carriage have historically been low. We identified trends in human fecal 
mcr-1-positivity rates and colonization with mcr-1-positive+third-generation 
cephalosporin-resistant (3GC-R) Enterobacteriaceae in Guangzhou, China, and 
investigated the genetic contexts of mcr-1 in a subset of mcr-1-positive+3GC-R strains. 
Methods 
Fecal samples were collected from in-patients and out-patients submitting specimens to 
three hospitals (2011-2016). mcr-1 carriage trends were assessed using iterative 
sequential regression. A subset of mcr-1-positive isolates was sequenced (whole genome 
sequencing [WGS], Illumina), and genetic contexts (flanking regions, plasmids) of mcr-1 
characterized.  
Results 
Of 8,022 fecal samples collected, 497 (6.2%) were mcr-1-positive, and 182 (2.3%) 
harbored mcr-1-positive+3GC-R Enterobacteriaceae. We observed marked increases in 
mcr-1 (0% [Apr/2011] to 31% [Mar/2016]) and more recent (since January 2014; 0% 
[Apr/2011] to 15% [Mar/2016]) increases in human colonization with mcr-1-
positive+3GC-R Enterobacteriaceae (p<0.001). mcr-1-positive+3GC-R isolates were 
commonly multi-drug resistant. 
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WGS of mcr-1-positive+3GC-R isolates (70 Escherichia coli, 3 Klebsiella pneumoniae) 
demonstrated bacterial strain diversity (48 E. coli sequence types); mcr-1 in association 
with common plasmid backbones (IncI, IncHI2/HI2A, IncX4) and sometimes in multiple 
plasmids; frequent mcr-1 chromosomal integration; and high mobility of the mcr-1-
associated insertion sequence ISApl1. Sequence similarity with published mcr-1 plasmid 
sequences was consistent with spread amongst animal/human reservoirs.  
Conclusions 
The high prevalence of mcr-1 in multidrug-resistant E. coli colonizing humans is a 
clinical threat; diverse genetic mechanisms (strains/plasmids/insertion sequences) have 
contributed to the dissemination of mcr-1, and will facilitate its persistence. 
MAIN TEXT 
INTRODUCTION 
Colistin is one of the antibiotics of last resort for managing multidrug-resistant Gram-
negative infections. Colistin resistance has historically largely been due to cell wall 
modifications, utilization of efflux pumps, and capsule formation(1). Transmissible, mcr-
1-mediated colistin resistance was recently identified in Escherichia coli and Klebsiella 
pneumoniae isolates from hospitalized humans, animals (pigs) and raw meat (pigs and 
chicken) in China(2), with higher rates in animal samples (~19% versus ~1% in humans).  
 
Subsequently, mcr-1-harboring strains have been identified in humans, animals and raw 
meat sampled globally (e.g.(3-13). These strains have predominantly been E. coli(14) or 
Salmonella spp.(3, 5), with up to 20% carriage prevalence in swine and poultry(6, 11), 
and mcr-1-positive isolates from chickens as early as the 1980s in China and 2007 in 
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France(6, 15). Prevalence in humans remains low(2, 4, 7, 10, 16), and mostly restricted to 
hospitalized patients(17, 18). However mcr-1 can be carried in the healthy human gut(18, 
19).  
 
The association of mcr-1 with other broad-spectrum resistance mechanisms, such as 
extended-spectrum β-lactamases (ESBLs) and/or carbapenemases(20-25), could represent 
a major clinical problem. The identification of mcr-1 in multiple plasmid types, including 
IncI2(2, 25), IncHI2(22), IncX4(12, 25), IncP(26) and IncF(23) plasmids, is consistent 
with multiple mcr-1 mobilization events, potentially facilitating the association of mcr-1 
with other resistance mechanisms, thereby creating multidrug-resistant bacterial hosts. 
In this study, we investigate human fecal carriage of mcr-1 and of mcr-1 in third-
generation cephalosporin-resistant (3GC-R)-Enterobacteriaceae in Guangzhou, China, 
over five years. Given that colistin resistance is of particular clinical relevance in the 
context of multi-drug resistance, we used whole-genome sequencing (WGS) to 
characterize a subset of 3GC-R isolates to identify relevant genetic structures, using 3GC 
resistance as a marker for wider multi-drug resistance.  
 
METHODS 
All in-patients and out-patients submitting any clinical specimens during the study 
timeframe to the hospital microbiology laboratories for diagnostic purposes were asked to 
participate in the study by means of an invitation included with the diagnostic test report 
returned to the patient. Samples came from three hospitals in Guangzhou, Guangdong 
province, serving a population of ~15 million over ~10,000 km2. Recruitment and sample 
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collection occurred continuously (except January 2012, February 2013 and February 
2014; holiday months, staff shortages); samples were not de-duplicated by patient. 
Ethical approval was given by Sun Yat-Sen University; individual consent for the use of 
fecal samples was obtained from patients.  
 
Fecal samples were collected into sterile fecal specimen containers and plated onto 
Columbia blood agar (CBA) within 2 hours of collection. A cotton swab was used to 
inoculate the agar with specimen (plate incubated for 18-24 hours, 37°C). Subsequently, 
up to 10 colonies of Enterobacteriaceae were sub-cultured to MacConkey 
agar+cefotaxime (2 mg/L), and species identification confirmed by 16S rDNA 
sequencing (see web-only Supplementary methods). All cefotaxime-resistant 
Enterobacteriaceae isolates were stored (lysogeny broth (LB)+30% glycerol, -80°C). 
Sweeps of cultured growth from the original CBA plates were also similarly stored. 
All frozen sweeps of cultured growth from feces (n=8,022) and individual cefotaxime-
resistant Enterobacteriaceae isolates (n=20,332) were subsequently re-cultured and 
screened for mcr-1 by PCR (see web-only Supplementary methods). Cefotaxime-resistant 
isolates were screened for blaCTX-M, and alleles determined by sequencing 
(Supplementary methods). Species identification for mcr-1 positive isolates was 
performed by API20E. Minimum inhibitory concentrations (MICs) were determined for 
all mcr-1-positive isolates by agar dilution (EUCAST breakpoints, version 6.0; Clinical 
and Laboratory Standards Institute, document M100-S25) (Fig.1). 
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Every cefotaxime-resistant, mcr-1-positive Enterobacteriaceae isolate of distinct species 
and MIC profile to May 2015 (n=45), and a random subset from June 2015-March 2016 
(n=44/142 [31%]) were selected for WGS. DNA was extracted using the cetyl-trimethyl-
ammonium bromide (CTAB)/chloroform method (Supplementary methods).  
 
DNA extracts were sequenced on the Illumina HiSeq 4000 platform at the Beijing 
Genomics Institute, using both paired-end (150bp reads, ~350bp insert) and mate-pair 
(50bp reads, ~6kb insert) approaches (n=69 isolates) or paired-end reads only (n=20 
isolates; Supplementary Table S1). Libraries were prepared using standardized protocols 
incorporating fragmentation by ultra-sonication, end repair, adaptor ligation, and PCR 
amplification (Supplementary methods).  
 
Preliminary species identification for isolates was derived from WGS using Kraken(27); 
read-data were then mapped to species-specific references(28). Hybrid de novo 
assemblies of paired-end and mate-pair data, or paired-end data alone, were generated 
using SPAdes(29) version 3.6 with the “--careful" option, a set of automatically 
determined k-mer values (21, 33, 55, 77), and by removing contigs <500bp or with k-mer 
coverage <1. In silico MLST was determined using BLASTn and publicly available 
databases (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli, 
http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html). Resistance genes were identified 
from de novo assemblies using a curated database of resistance genes(30) and 
BLASTn/mapping-based identification (scripts available at: 
https://github.com/hangphan/resistType). Contigs were annotated using PROKKA(31). 
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Contigs containing mcr-1 were defined as “plasmid” if they contained annotations 
consistent with plasmid-associated loci and no obvious chromosomal loci, or 
“chromosomal” if >75% of annotations (excluding hypothetical proteins) were consistent 
with a chromosomal location.  
 
The integrity of assemblies containing mcr-1 in chromosomal locations was assessed 
using REAPR(32). We excluded any sequences with assembly sizes ≥6.5Mb and/or 
mixed calls from in silico species identification/MLST. 
 
The phylogeny was reconstructed using IQtree(33). Branch lengths were corrected for 
recombination using ClonalFrameML(34)(Supplementary methods). The phylogeny was 
represented in the interactive tree of life viewer (iTOL v3, http://itol.embl.de). Insertion 
sequences (IS) were downloaded from ISFinder (https://www-is.biotoul.fr); sequence 
assemblies were queried against this database with BLASTn (requiring >95% sequence 
identity over >90% of the reference sequence length).  
 
Circularization of mcr-1-harboring plasmid contigs was confirmed using Bandage(35). 
For single mcr-1-harboring plasmid contigs which were not circularizable, we also used 
Bandage to visualize the sequencing assembly graph generated by SPAdes and manually 
resolved the most likely mcr-1 plasmid structures based on node (contig) linkage and 
contig coverage (Supplementary methods).  
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Iterative sequential regression (ISR) in R was used to characterize trends in fecal mcr-1 
positivity (Supplementary methods).  
 
Sequence data have been deposited in NCBI (BioProject: PRJNA354216; Supplementary 
Table S1). 
 
RESULTS 
Trends in fecal mcr-1 prevalence, and fecal mcr-1/cefotaxime-resistant 
Enterobacteriaceae prevalence 
Sweeps of cultured growth from 497/8,022 fecal samples (6.2%) were mcr-1 PCR-
positive, and 182 (2.3%) fecal samples harbored mcr-1-positive+cefotaxime-resistant 
Enterobacteriaceae (Fig.2). The proportion of both mcr-1-positive and mcr-1-
positive+cefotaxime-resistant samples increased significantly over time (p<0.001). For 
mcr-1-positive+cefotaxime-resistant samples, this was driven specifically by increases 
after January 2014 (p<0.001, Fig.2; 95% CI for estimated date of trend change: 
01/April/2013-01/Nov/2014). There was no evidence of a change in fecal sampling rates 
over time (negative binomial regression; incidence rate ratio [IRR] 1.02 (95% CI 0.96-
1.08), p-value = 0.6). 
 
From fecal samples harboring mcr-1-postive+cefotaxime-resistant Enterobacteriaceae, 
187 distinct isolates from 182 fecal samples from 179 individuals were identified (E. coli, 
n=173; K. pneumoniae, n=13; Enterobacter cloacae, n=1). Of these, 23 isolates from 22 
individuals had ertapenem MICs of ≥0.5mg/L (earliest isolate in 2013). 144/179 (80%) 
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individuals were hospital in-patients at sampling (median stay 14 days [range: 3-258 
days; IQR: 7-21 days]).  
 
Whole genome sequencing of mcr-1+cefotaxime-resistant Enterobacteriaceae 
Species and strain-level diversity 
Of 89/187 isolates selected for WGS (see methods), 11/45 consecutive isolates pre-May 
2015 and 5/44 randomly selected isolates post-June 2015 failed quality control (Table 
S1), leaving 73 sequences for analysis (70 E. coli, 3 K. pneumoniae). For E. coli, these 
represented 48 sequence types (STs) (Fig.3), ST156 being the most common (n=5), with 
most isolates (n=33) representing singleton STs. Other global disease-causing lineages 
were also identified, including ST131, ST155 and ST405(36), and for K. pneumoniae, 
ST15 and ST307. Four pairs of isolates were separated by 0 SNVs 
(SYSU0077/SYSU0078; SYSU0002/SYSU0009; SYSU0014/SYSU0015; 
SYSU0025/SYSU0026), and one pair by 3 SNVs (SYSU0041/SYSU0049), representing 
likely direct/indirect transmissions between patients. All others were >1126 SNVs apart. 
 
mcr-1 and insertion sequence diversity 
A novel mcr-1 allele was identified (G3A; loss of the first methionine [n=2; SYSU0052, 
SYSU0010]); these isolates remained colistin-resistant. Another isolate had mcr-1 
disrupted by an IS1294 element, previously described downstream of mcr-1 (n=1; 
SYSU0039)(8).  
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Insertion sequences may contribute to plasmid-plasmid and plasmid-chromosome 
rearrangements and gene mobilization. We found 99 different IS types in the 73 
sequenced isolates, with median 15 (range: 7-29) IS types per isolate.  
 
Antimicrobial susceptibility profiles and mechanisms of multi-drug resistance in mcr-1-
positive+cefotaxime-resistant Enterobacteriaceae 
Rates of cross-class resistance in mcr-1-positive+cefotaxime-resistant isolates were high 
(Table 1); only carbapenems, nitrofurantoin and tigecycline demonstrated susceptibility 
rates ≥80% (similar rates in subset of sequenced isolates [Table 1]). Amongst the 
sequenced isolates, 58/73 (79%) harbored blaCTX-M, including: (i) group 9-like alleles: 
14(n=22), 27(4), 65(7), 110(1), 130(1); (ii) group 1-like alleles: 1-like(n=1), 3 (n=1), 
11(1), 55/55-like(21), 136(1); and (iii) hybrid alleles: 64(3), 123(2). Thirteen (18%) 
sequenced isolates had two blaCTX-M variants, and in three (carrying blaCTX-M-
14,27/55,55/123), blaCTX-M was located on the same contig as mcr-1. For eleven (15%) 
isolates, no cefotaxime resistance mechanism could be identified (Table S1). Multiple 
other resistance genes were identified; three isolates harbored blaCMY and one blaDHA 
(Table S1). In carbapenem non-susceptible isolates that were sequenced (6/23), no genes 
encoding carbapenemases were identified; carbapenem non-susceptibility in these 
isolates was attributed to the presence of ESBLs (blaCTX-M, blaOXA-10) + porin gene 
mutations. 
 
Genetic (plasmid/chromosomal) contexts of mcr-1 
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The genetic context of mcr-1 was diverse. In 62/73 (85%) isolates mcr-1 was located on 
plasmid-associated contigs, in 4 (5%) on chromosomal contigs, in 2 (5%) likely on 
chromosomal contigs, and in 5 (7%) the location was unclear due to assembly/annotation 
limitations. mcr-1 copy number per sequenced isolate was estimated at 0.27-3.54 (median 
0.97); copy number values >1 were likely due to its presence either on multi-copy 
plasmids; as multiple copies within the same plasmid (e.g. SYSU0077 [IncH]; 
SYSU0093 [IncI2]); or on different plasmids within the same isolate (e.g. SYSU0072 
[IncH and IncX4]; SYSU0220 [novel plasmid described below]).  
 
mcr-1 on IncI plasmids 
In 27/62 (44%) isolates where mcr-1 was plasmid-associated, it was co-located with an 
IncI2 replicon (n=16). Fourteen sequences represented circularizable, complete plasmid 
structures; this included the earliest sequenced mcr-1 plasmid, to our knowledge 
(SYSU0011, May 2011).  
 
In these plasmids, the backbone and mcr-1 location were largely preserved; this was also 
true of the six non-circularizable IncI contigs harbouring mcr-1 (Fig.4). In relation to 
mcr-1, we observed variable presence of ISApl1, but when present, it was always located 
upstream of mcr-1 between mcr-1 and nikB, most consistent with ancestral ISApl1-
mediated acquisition of mcr-1 into an IncI plasmid backbone, and subsequent loss of 
ISApl1. These plasmids were also undergoing significant evolution by 
mutation/recombination, rearrangement, indels, and acquisition/loss of smaller mobile 
genetic elements (MGEs), such as ISEcp1+blaCTX-M-55 (SYSU0060, SYSU0045; Fig.4). 
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The mcr-1-IncI2 plasmids were also genetically highly similar to three previously 
sequenced plasmids (Fig.4): SZ02 (Accession number: KU761326, blood culture, August 
2015, Suzhou); the blaCTX-M-55-harboring pA31-12 (Accession number: KX034083.1, 
chicken, August 2012, Guangzhou), and pHNSHP45 (Accession number: KP347127.1, 
pig, July 2013, Shanghai), consistent with the dissemination of this plasmid in human 
cases/carriers, pigs and chickens across China. 
 
We also observed highly genetically related IncI plasmid backbones in two different E. 
coli host strains (ST156, 354; SYSU0060, SYSU0062) isolated from the same 
patient/same day, potentially consistent with within-host transfer, as well as highly 
genetically related plasmids within different E. coli strains and humans across periods of 
time consistent with direct transmission/acquisition from common sources (SYSU0019, 
SYSU0007).  
 
mcr-1 on IncHI2/HI2A plasmids 
In 10/62 (34%) isolates where mcr-1 was plasmid-associated, it co-localized with either 
IncHI2/HI2A (n=7), or was plausibly on an IncHI2 plasmid (n=12). As these plasmids 
are large and more likely to include repeats, we were unable to fully reconstruct them. 
Five contigs were short (<3,000bp); the others are represented in Fig.5, alongside two 
closed reference mcr-1-IncHI2 plasmids, pSA26 (Accession number: KU743384, blood 
culture, Saudi Arabia), and pHNSHP45-2 (Accession number: KU341381, pig feces, 
Shanghai). These demonstrate that a homogenous backbone sequence ranging from 
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~38kbp to ~224kbp (of evaluable sequence) has been circulating within the study 
population between 2012-early 2016, likely derived from an ancestral plasmid similar to 
the reference plasmids (Fig.5).  
 
We observed apparently frequent IS/transposon-associated indel events in mcr-1-
IncHI/HI2A plasmids, including of ISApl1, which was either at the 5’ end of mcr-1 
(SYSU0003), flanking it on both sides (SYSU0014), or absent (SYSU0026). As mcr-1 
was located in the same wider genetic context in 14/17 study plasmid contigs, this likely 
represents a single ISApl1-mcr-1-ISApl1 acquisition and subsequent loss of ISApl1 
elements(37), similar to that seen in mcr-1-IncI plasmids in this study. Alternatively it 
could represent a genetic “hotspot” facilitating multiple ISApl1-mcr-1-ISApl1 insertion 
events. 
 
We also observed a mcr-1 duplication event within otherwise identical plasmid sequences 
in two isolates taken 7 days apart (SYSU0077, SYSU0078); and inversions of ISApl1-
mcr-1 within the backbone (SYSU0002, SYSU0009, SYSU0055), all consistent with 
high rates of plasticity involving ISApl1-mcr-1 and IncHI2/HI2A structures.  
 
mcr-1 on IncX4 plasmids 
In 15/62 (24%) isolates where mcr-1 was plasmid-associated, it co-localized (n=10) or 
was plausibly associated with (n=5) an IncX4 replicon; seven of these represented 
circularizable plasmid sequences (Fig.6). IncX4-mcr-1 plasmids had a highly conserved, 
syntenic backbone, with limited nucleotide and indel variation over 2.5 years. They were 
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also highly similar to two reference IncX4-mcr-1 plasmids, SZ04 (peritoneal fluid, 
Suzhou) and pAF48 (urine, Johannesburg, South Africa), consistent with national and 
international spread. ISApl1 was absent in all of these plasmids, but IS26-like elements 
were located upstream of mcr-1, suggesting the mechanism of mobilization to IncX4 is 
different from that in IncI and IncHI2/HI2A plasmids.  
 
Other genetic contexts of mcr-1 
In 8/73 (11%) sequenced isolates no associated plasmid replicon could be identified. In 
one isolate (SYSU0220) we identified a new mcr-1 harboring plasmid (48,944bp, Fig.S1) 
similar to pHNFP671 (accession number: KP324830.1, IncP, pig feces, isolated prior to 
2014). 
 
Chromosomal mcr-1 integration was confirmed in four E. coli STs (457, 1114, 1684, 
2936), and plausibly in two others (101, 2705), consistent with at least 4 independent 
chromosomal integration events in diverse strains (5% sequenced E. coli isolates), 
suggesting capacity for non-lineage-specific vertical dissemination of mcr-1.  
 
DISCUSSION 
Widespread transmissible colistin resistance is of major concern in the context of 
multidrug-resistance, as colistin is commonly used to treat infections caused by MDR-
Enterobacteriaceae, despite its drawbacks(39, 40). In this, the largest study of human 
fecal carriage and WGS of mcr-1 isolates to our knowledge, we observed alarming 
sequential increases in carriage of mcr-1, and of mcr-1-positive+cefotaxime-resistant 
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Enterobacteriaceae fecal carriage (predominantly E. coli) over five years. We also found 
significant diversity and genetic plasticity of MGEs harboring mcr-1 that may explain 
some of these dramatic increases. 
 
IncI plasmids are narrow host-range plasmids(41), commonly isolated from E. coli and 
Salmonella spp., and implicated in the spread of the ESBL gene blaCTX-M amongst 
Enterobacteriaceae, particularly in China(42, 43). CTX-M-55 has been found in E. coli 
in animals in China, and CTX-M-55/55-like variants were seen with mcr-1 in IncI2 
plasmids in two different E. coli strains (ST156, ST117) in this study. Previously, it has 
been postulated that an IncI2 plasmid backbone acquired a 3,080bp ISEcp1-blaCTX-M-15 
complex from an IncA/C plasmid, with a mutation resulting in conversion to blaCTX-M-55 
within this structure(44). The same signature sequence was observed in our isolates, as 
well as another recently sequenced IncI2 plasmid harboring blaCTX-M-55 from a chicken E. 
coli isolate in Guangzhou (August 2012)(45), consistent with the spread of this plasmid 
across humans and animals. blaCTX-M-64 was also observed on an IncI mcr-1 plasmid in 
this study (SYSU0115, ST155); this allele is thought to have arisen from recombination 
between blaCTX-M-14 and blaCTX-M-15 on IncI plasmids in food animals in China(44). 
 
IncHI2/HI2A plasmids are typically large (>250kb)(46), multidrug-resistant plasmids that 
have been associated with a range of antibiotic and metal resistance genes in Salmonella 
spp. and E. coli isolated from humans and food-producing animals(47). Similar to the 
IncI plasmids, our genetic analyses suggest an initial mcr-1 acquisition event, and 
subsequent loss of ISApl1 units and rearrangements of the plasmid backbone.  
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In at least four sequenced isolates, mcr-1 had been integrated into the chromosome, a 
phenomenon observed in at least two other studies (E. coli ST156, Beijing (48); E. coli 
ST410, Germany (49)). Our data suggest two additional mcr-1 chromosomal integrations 
- one in association with an integrative element promoting IS activity, and one in 
association with an ISEc23/IS30-like/IS1294 element, which has played a role in the 
mobilization of blaCMY-2 in Salmonella spp. and E. coli(50). The multifarious means by 
which chromosomal integration of mcr-1 appears to occur is of concern, as this may 
facilitate more stable inheritance of this gene. 
 
The variable extent of genetic diversity observed within the plasmid families here 
(IncHI2/HI2A and IncI > IncX4) may reflect different evolutionary rates for these 
plasmid families, or may be consistent with earlier acquisition of ISApl1-mcr-1 
composite transposons by IncHI2/HI2A and IncI2, most likely within poultry and pig 
farms in which regular colistin exposure represents a major selection pressure(2). The 
acquisition of mcr-1 by IncX4 plasmids appears to be unrelated to the presence of 
ISApl1, and possibly involves IS26/26-like structures.  
 
This study has several limitations. Firstly, although we observed significant increases in 
fecal carriage of mcr-1-harboring isolates, we did not assess possible risk factors 
associated with increasing incidence. We did not de-duplicate samples by patient for the 
whole dataset; however, analysis of participant study identifiers for the mcr-1/3GC-
resistant isolates suggests that replicate sample submission was minimal (~2%), and 
 18 
would not have explained the incidence trends observed. We only investigated the 
culturable component of feces for overall mcr-1 prevalence, as DNA was extracted from 
sweeps of cultured feces, and we may therefore have underestimated true mcr-1 
colonization by not performing PCR direct on DNA extracts from whole feces. Our WGS 
strategy only targeted culturable, cefotaxime- and colistin-resistant isolates from feces, as 
we were predominantly interested in investigating the genomic epidemiology of multi-
drug resistant Enterobacteriaceae. The diversity of strains and MGEs harboring mcr-1 
may therefore be even greater. We did not screen for mcr-2, which has also been shown 
to confer colistin resistance, nor did we screen potential animal or non-human reservoirs. 
Finally, due to resource limitations we were unable to sequence all mcr-1-positive 
isolates, or to re-sequence those that failed. We were also unable to undertake any long-
read sequencing, increasingly the method of choice in assembling plasmids. 
 
Despite these limitations, we have demonstrated that human fecal carriage of mcr-1 
positive E. coli has increased dramatically in Guangzhou over the last two years, reaching 
similar proportions (20-30%) to animals (pigs, chickens) over the preceding 3-4 years in 
the same region of China(2). Our genetic analyses suggest the rapid emergence of several 
major plasmid vectors of mcr-1 within numerous multidrug-resistant E. coli strains 
carried by humans, and highlight the significant degree of plasticity in these plasmid 
vectors harboring mcr-1 over short periods of time.  
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TABLES 
Table 1. Antimicrobial susceptibility profiles of mcr-1-positive Enterobacteriaceae isolates obtained following selective 
screening culture of feces on agar supplemented with cefotaxime (2 mg/L).  
  Number of isolates resistant (%) 
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All isolates 
(n=187) 
183 
(98) 
176 
(94) 
165 
(88) 
131 
(70) 
139 
(74) 
179 
(96) 
130 
(70) 
47 
(25) 
23 
(12) 
4  
(2) 
16 
(9) 
101 
(54) 
19 
(10) 
152 
(81) 
24 
(13) 
Sequenced 
isolates 
(n=73) 
73 
(100) 
 
59 
(81) 
67a  
(92) 
60 
(82) 
57  
(78) 
71 
(97) 
54 
(74) 
20 
(27) 
6  
(8) 
0  
(0) 
0  
(0) 
43 
(59) 
5  
(7) 
 
63 
(86) 
9 
(12) 
 
a six isolates had MICs of ≤1 (susceptible) when tested following selective screening culture. Of these, one harbored blaCTX-M-55 
and one blaCTX-M-65; for the other four, no discernible third generation cephalosporin resistance mechanism was identified 
following re-culture and DNA extraction for WGS. 
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FIGURE LEGENDS 
Figure 1. Flow diagram summarizing sampling/laboratory/sequencing workflows. 
 
Figure 2. Monthly proportions of mcr-1-positive human fecal samples in Guangzhou, 
China, 2011-2016 for: Panel A, fecal samples harboring mcr-1-positive isolates, and 
Panel B, fecal samples harboring mcr-1-positive/cefotaxime-resistant isolates. Black line 
represents estimated prevalence by iterative sequential regression (ISR), with gaps 
representing months with missing data. Blue lines at the base of the graph represent 95% 
confidence intervals around the breakpoints estimated by the ISR model. Panel C, raw 
counts for each category and sampling denominator (total number of fecal samples), by 
calendar year (or partial year as specified).   
 
Figure 3. Phylogeny of sequenced Escherichia coli study isolates, plus available 
reference sequences from NCBI (n=11), and associated sequence types (ST; “NF” 
denotes “not found”); plasmid incompatibility groups; insertion sequences within 5kb of 
mcr-1 on either the same contig or contigs associated through the assembly graph; and 
antimicrobial resistance genes present within the isolates (presence represented by 
respective coloured shapes).  
  
Figure 4. Alignment of mcr-1 IncI2 study plasmids (complete plasmids, denoted by * if 
circularized using SPAdes assembly only, and by ** if circularized using 
SPAdes+Bandage); incompletely resolved plasmid contigs; and three reference plasmid 
sequences (sequence labels in bold). Dates of isolation are shown on the right side. Two 
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plasmid sequences were obtained from isolates cultured from the same patient (sequence 
labels in blue). Pink/blue cross-links between aligned sequences demonstrate regions of 
sequence homology (BLASTn matches of ≥500bp length, >95% sequence identity); dark 
regions within these cross-links demonstrate sequence variation. Tick marks represent 
10kb of sequence. Colored arrows demonstrate ORFs of particular relevance; additional 
coding sequence annotations are shown above reference plasmid SZ02.  
 
Figure 5. Alignment of mcr-1 IncHI2/HI2A plasmid contigs and two reference plasmid 
sequences (sequence labels in bold followed by dates of host strain isolation). Pink/blue 
cross-links between aligned sequences demonstrate regions of sequence homology 
(BLASTn matches of ≥500bp length, >95% sequence identity); dark regions within these 
cross-links demonstrate sequence variation. Tick marks represent 10kb of sequence. 
Colored arrows demonstrate ORFs of particular relevance. 
 
Figure 6. Alignment of mcr-1 IncX4 study plasmids (complete plasmids, denoted by * if 
circularized using SPAdes assembly only, and by ** if circularized using 
SPAdes+Bandage); incompletely resolved plasmid contigs; and three reference plasmid 
sequences (sequence labels in bold). Dates of isolation are shown on the right side. 
Pink/blue cross-links between aligned sequences demonstrate regions of sequence 
homology (BLASTn matches of ≥500bp length, >95% sequence identity); dark regions 
within these cross-links demonstrate sequence variation. Tick marks represent 10kb of 
sequence. Colored arrows demonstrate ORFs of particular relevance. Three contigs were 
excluded as they were small (2.0-8.75kb). 
